Sign in to view content

BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing

Eric W Schneider, MD

Video
Published 2019

Related

Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema
Thomas A. Ciulla, MD, MBA, FASRS
Updates from the Field
2017
Interview Reversal of Retinal Ischemia After Anti-VEGF Therapy
Thomas R. Friberg, MD
Updates from the Field
2019
New Biomarkers of Angiogenesis in AMD Using OCT Angiography
David Sarraf, MD
Updates from the Field
2017

Category: AMD-Neovascular

See more